Navigation Links
MiMedx Announces Record Third Quarter Results

MARIETTA, Ga., Oct. 30, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

Highlights of third quarter of 2013 results include:

  • Revenue exceeds high end of guidance (8th consecutive quarter of meeting or exceeding upper end of guidance)
  • Revenue increased more than 100% over third quarter of 2012
  • Nine-month revenue increased nearly 150% over same period of 2012
  • 7th consecutive quarter of positive Adjusted EBITDA
  • Quarterly Cash Flow from Operations Positive for the First time in Company History
  • Company reiterates increased lower end of 2013 full year revenue guidance
  • Third Quarter 2013 Results
    The Company recorded record revenue for the quarter ended September 30, 2013, with revenue of $16.1 million, an increase of more than 100% over third quarter of 2012 revenue of $8.0 million. The Company's third quarter gross margins were 87% as compared to gross margins of 82% in the third quarter of last year.  Earnings before interest, taxes, depreciation, amortization and share based compensation (Adjusted EBITDA*) for the third quarter of 2013 were $1.9 million, a $1.1 million  or  156% improvement, as compared to the Adjusted EBITDA of $726,000 for the third quarter of 2012. The Net Loss for the third quarter of 2013 was $307,000 as compared to net loss of $4.2 million in the prior year third quarter. The prior year Net Loss included a $1.8 million Intangible Asset impairment charge and a $1.3 million charge related to the fair value adjustment of the earn-out liability related to the acquisition of Surgical Biologics. 

    SOURCE MiMedx
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. MiMedx Reports On Meeting With FDA
    2. MiMedx Responds To Misleading And Inaccurate Media Reports
    3. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
    4. MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference
    5. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
    6. MiMedx Announces Record Second Quarter Results
    7. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
    8. MiMedx To Exceed High End Of Second Quarter Guidance
    9. MiMedx to Ring NASDAQ Stock Market Opening Bell
    10. MiMedx to Present at Jefferies 2013 Global Healthcare Conference
    11. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
    Post Your Comments:
    (Date:3/5/2015)... BioPlus Specialty Pharmacy (BioPlus) announces the hiring ... of Managed Care. In this role, Damm will build ... nation’s leading specialty pharmacies. , Damm, who is based ... pharmacy and biotech experience to his new position with ... and Pfizer. Prior to working in Healthcare Damm served ...
    (Date:3/5/2015)... Park, NC (PRWEB) March 05, 2015 ... announced that Pierre Noel, M.D., Professor of Medicine, ... to the Company’s Board of Directors. ... “We are extremely fortunate to have Dr. Noel, ... country’s leading healthcare organization, join Entegrion’s Board. His ...
    (Date:3/5/2015)... Conn. , March 5, 2015  UBM ... , a leading online community to help ... of the newest information available regarding the use ... of kidney cancer. March is ... are very few effective adjuvant treatment options for ...
    (Date:3/5/2015)...  In response to the incorrect assertions by LD, ... on February 12, 2015. Impeto Medical SAS and ... and their SUDOSCAN® devices have been proven to provide ... to have the courts decide this dispute rather than ... articles written by Key Opinion Leaders, published by significant ...
    Breaking Biology Technology:BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2OncoTherapy Network Highlights Kidney Cancer Awareness Month 2OncoTherapy Network Highlights Kidney Cancer Awareness Month 3Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2
    ... MailFoundry , a provider of anti-spam appliances and solutions, ... spam tactics known as botnet e-mail harvesting ... company's chief executive said the new RedListing anti-spam layer, produced ... no false positives and realtime detection capabilities. , ,David C. ...
    ... Madison, Wis. - With its first accelerator building fully ... ground this spring on a new, 50,000 square foot Accelerator ... to Third Wave Technologies, will help firms that are ready ... incubator for start-up technology companies. Suites will range in size ...
    ... , director of technology programs for the University of Wisconsin-Madison, ... as he demonstrates in Part II of this interview. In ... issues. In Part II (below), he addresses creating a culture ... Converse also is a featured speaker at the Fusion ...
    Cached Biology Technology:Research park to add accelerator suites 2
    (Date:2/5/2015)...  It is gratifying to see that the Obama ... science as a means to better understand human biology, ... was honored to participate in today,s White House event ... Since the 1980s my teams have been ... sequenced genome of a free living organism, the first ...
    (Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
    (Date:1/22/2015)... Jan. 16, 2015  A man-made form of insulin delivered ... mental capabilities in adults with mild cognitive impairment and ... by researchers at Wake Forest Baptist Medical Center. ... amnesic mild cognitive impairment (MCI) or mild to moderate ...
    Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
    ... This release is available in German . ... interglacial epoch, around 115,000 years ago, there were significant ... transition from the Eemian Interglacial to the Weichselian Glacial ... with possibly at least two warming events. This is ...
    ... Sergiu M. Gorun, PhD, associate professor of chemistry ... , was awarded a patent today for ... Compositions of Perfluoroalkyl Perfluoro-Phthalocyanine Compounds" (US Patent Number ... These new materials are comprised of organic ...
    ... Blacksburg, Va. A scientific paper that describes a ... biological processes has exceeded 500 citations in the ISI ... the impact of scientific publications. The Systems Biology Markup ... quantitative models of biochemical networks between different computer software ...
    Cached Biology News:Were short warm periods typical for transitions between interglacial and glacial epochs? 2NJIT researcher awarded patent for hydrophobic, corrosion-resistant coating 2After 5 years, free systems biology markup language has proven popular 2After 5 years, free systems biology markup language has proven popular 3
    Mouse Wnt-11 Affinity Purified Polyclonal Ab...
    [14C]Polyethylene glycol 4000, 9.25 MBq, 250 uCi. Aqueous solution containing 3% ethanol, sterilized. 370-740 MBq/g, 10-20 mCi/g.1.85 MBq/ml, 50 uCi/ml. Category: Radiochemicals &Radiation Safety, ...
    Use the DUALmembrane kit 3 to carry out DUALmembrane interaction analysis and cDNA library screening to characterize interactions between integral membrane proteins and to identify novel interaction ...
    Biology Products: